Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Aug;74(3):439–445. doi: 10.1038/bjc.1996.378

Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration.

H Tobioka 1, N Sawada 1, Y Zhong 1, M Mori 1
PMCID: PMC2074641  PMID: 8695361

Abstract

To study pathophysiological roles of mesothelial barrier functions in protection against cancer cell invasion, we isolated mesothelial cells from the rat abdominal cavity and then cultured them with 10(-6)M all-trans-retinoic acid (RA) for 10 days. Mesothelial barrier function assessed by measuring transcellular electrical resistance (TER) and the expression of 7H6 tight junction-associated antigen at the cell border were induced by the treatment (10.01 +/- 0.8 vs 6.05 +/- 0.7 omega cm2, without RA; mean +/- s.e.m., n = 10). Then we quantified the attachment and penetration of rat mammary cancer cells (SST-2 cells) into the mesothelial cell monolayer by prelabelling of the cancer cells with fluorescent dye and by observing optical sections at different heights using a laser confocal scanning microscope. When SST-2 cells were overlaid onto the mesothelial cell monolayer treated with RA, the number of cancer cells found at the basal level of the monolayer was significantly reduced. These results showed that enhanced mesothelial barrier function at least partially prevents the penetration of cancer cells into mesothelial cells and suggested that 7H6 antigen serves as a reliable immunocytochemical marker for monitoring mesothelial barrier function.

Full text

PDF
439

Images in this article

441Figure 1
on p.441
441Figure 2
on p.441
442Figure 4
on p.442
443Figure 5
on p.443
443Figure 7
on p.443
444Figure 8
on p.444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akedo H., Shinkai K., Mukai M., Komatsu K. Potentiation and inhibition of tumor cell invasion by host cells and mediators. Invasion Metastasis. 1989;9(2):134–148. [PubMed] [Google Scholar]
  2. Akedo H., Shinkai K., Mukai M., Mori Y., Tateishi R., Tanaka K., Yamamoto R., Morishita T. Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. Cancer Res. 1986 May;46(5):2416–2422. [PubMed] [Google Scholar]
  3. Albini A., Iwamoto Y., Kleinman H. K., Martin G. R., Aaronson S. A., Kozlowski J. M., McEwan R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987 Jun 15;47(12):3239–3245. [PubMed] [Google Scholar]
  4. Asplund T., Heldin P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 1994 Aug 15;54(16):4516–4523. [PubMed] [Google Scholar]
  5. Bermudez E., Everitt J., Walker C. Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture. Exp Cell Res. 1990 Sep;190(1):91–98. doi: 10.1016/0014-4827(90)90148-4. [DOI] [PubMed] [Google Scholar]
  6. Carson M. R., Shasby S. S., Shasby D. M. Histamine and inositol phosphate accumulation in endothelium: cAMP and a G protein. Am J Physiol. 1989 Oct;257(4 Pt 1):L259–L264. doi: 10.1152/ajplung.1989.257.4.L259. [DOI] [PubMed] [Google Scholar]
  7. Chertow B. S., Baranetsky N. G., Sivitz W. I., Meda P., Webb M. D., Shih J. C. Cellular mechanisms of insulin release. Effects of retinoids on rat islet cell-to-cell adhesion, reaggregation, and insulin release. Diabetes. 1983 Jun;32(6):568–574. doi: 10.2337/diab.32.6.568. [DOI] [PubMed] [Google Scholar]
  8. Claude P. Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol. 1978 Mar 10;39(2-3):219–232. doi: 10.1007/BF01870332. [DOI] [PubMed] [Google Scholar]
  9. Donna A., Betta P. G., Cosimi M. F., Robutti F., Bellingeri D., Marchesini A. Putative mesothelial cell growth-promoting activity of a cytoplasmic protein expressed by the mesothelial cell. A preliminary report. Exp Cell Biol. 1989;57(4):193–197. doi: 10.1159/000163525. [DOI] [PubMed] [Google Scholar]
  10. Faris R. A., McBride A., Yang L., Affigne S., Walker C., Cha C. J. Isolation, propagation, and characterization of rat liver serosal mesothelial cells. Am J Pathol. 1994 Dec;145(6):1432–1443. [PMC free article] [PubMed] [Google Scholar]
  11. Hamada J., Takeichi N., Kobayashi H. Inverse correlation between the metastatic capacity of cell clones derived from a rat mammary carcinoma and their intercellular communication with normal fibroblasts. Jpn J Cancer Res. 1987 Nov;78(11):1175–1178. [PubMed] [Google Scholar]
  12. Hart I. R., Fidler I. F. An in vitro quantitative assay for tumor cell invasion. Cancer Res. 1978 Oct;38(10):3218–3224. [PubMed] [Google Scholar]
  13. Harvey W., Amlot P. L. Collagen production by human mesothelial cells in vitro. J Pathol. 1983 Mar;139(3):337–347. doi: 10.1002/path.1711390309. [DOI] [PubMed] [Google Scholar]
  14. Horai T., Imamura F., Nakae T., Nakamura S., Mukai M., Shinkai K., Higashino K., Akedo H. Interactions of lung cancer cells with the human mesothelial cell monolayer: an in vitro model for cancer invasion. Jpn J Clin Oncol. 1992 Apr;22(2):67–72. [PubMed] [Google Scholar]
  15. Imamura F., Horai T., Mukai M., Shinkai K., Akedo H. Potentiation of invasive capacity of rat ascites hepatoma cells by adriamycin. Cancer Res. 1990 Apr 1;50(7):2018–2021. [PubMed] [Google Scholar]
  16. Imamura F., Horai T., Mukai M., Shinkai K., Akedo H. Serum requirement for in vitro invasion by tumor cells. Jpn J Cancer Res. 1991 May;82(5):493–496. doi: 10.1111/j.1349-7006.1991.tb01877.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Imamura F., Horai T., Mukai M., Shinkai K., Sawada M., Akedo H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem Biophys Res Commun. 1993 Jun 15;193(2):497–503. doi: 10.1006/bbrc.1993.1651. [DOI] [PubMed] [Google Scholar]
  18. Isoai A., Giga-Hama Y., Shinkai K., Mukai M., Akedo H., Kumagai H. Purification and characterization of tumor invasion-inhibiting factors. Jpn J Cancer Res. 1990 Sep;81(9):909–914. doi: 10.1111/j.1349-7006.1990.tb02666.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Isoai A., Giga-Hama Y., Shinkai K., Mukai M., Akedo H., Kumagai H. Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells. Cancer Res. 1992 Mar 15;52(6):1422–1426. [PubMed] [Google Scholar]
  20. Ke Y., Reddel R. R., Gerwin B. I., Reddel H. K., Somers A. N., McMenamin M. G., LaVeck M. A., Stahel R. A., Lechner J. F., Harris C. C. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am J Pathol. 1989 May;134(5):979–991. [PMC free article] [PubMed] [Google Scholar]
  21. Kim K. H., Stellmach V., Javors J., Fuchs E. Regulation of human mesothelial cell differentiation: opposing roles of retinoids and epidermal growth factor in the expression of intermediate filament proteins. J Cell Biol. 1987 Dec;105(6 Pt 2):3039–3051. doi: 10.1083/jcb.105.6.3039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kimura A., Koga S., Kudoh H., Iitsuka Y. Peritoneal mesothelial cell injury factors in rat cancerous ascites. Cancer Res. 1985 Sep;45(9):4330–4333. [PubMed] [Google Scholar]
  23. Kiyasu Y., Kaneshima S., Koga S. Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res. 1981 Mar;41(3):1236–1239. [PubMed] [Google Scholar]
  24. LaRocca P. J., Rheinwald J. G. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res. 1984 Jul;44(7):2991–2999. [PubMed] [Google Scholar]
  25. Laposata M., Dovnarsky D. K., Shin H. S. Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro. Blood. 1983 Sep;62(3):549–556. [PubMed] [Google Scholar]
  26. Li X., Nagayasu H., Hamada J., Hosokawa M., Takeichi N. Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta. Jpn J Cancer Res. 1993 Nov;84(11):1145–1149. doi: 10.1111/j.1349-7006.1993.tb02814.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Liotta L. A., Lee C. W., Morakis D. J. New method for preparing large surfaces of intact human basement membrane for tumor invasion studies. Cancer Lett. 1980 Dec;11(2):141–152. doi: 10.1016/0304-3835(80)90105-6. [DOI] [PubMed] [Google Scholar]
  28. Madara J. L., Parkos C., Colgan S., Nusrat A., Atisook K., Kaoutzani P. The movement of solutes and cells across tight junctions. Ann N Y Acad Sci. 1992;664:47–60. doi: 10.1111/j.1749-6632.1992.tb39748.x. [DOI] [PubMed] [Google Scholar]
  29. Molony L., Armstrong L. Cytoskeletal reorganizations in human umbilical vein endothelial cells as a result of cytokine exposure. Exp Cell Res. 1991 Sep;196(1):40–48. doi: 10.1016/0014-4827(91)90454-3. [DOI] [PubMed] [Google Scholar]
  30. Mukai M., Shinkai K., Komatsu K., Akedo H. Potentiation of invasive capacity of rat ascites hepatoma cells by transforming growth factor-beta. Jpn J Cancer Res. 1989 Feb;80(2):107–110. doi: 10.1111/j.1349-7006.1989.tb02275.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mukai M., Shinkai K., Tateishi R., Mori Y., Akedo H. Macrophage potentiation of invasive capacity of rat ascites hepatoma cells. Cancer Res. 1987 Apr 15;47(8):2167–2171. [PubMed] [Google Scholar]
  32. Niedbala M. J., Crickard K., Bernacki R. J. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Exp Cell Res. 1985 Oct;160(2):499–513. doi: 10.1016/0014-4827(85)90197-1. [DOI] [PubMed] [Google Scholar]
  33. Pronk A., Leguit P., Hoynck van Papendrecht A. A., Hagelen E., van Vroonhoven T. J., Verbrugh H. A. A cobblestone cell isolated from the human omentum: the mesothelial cell; isolation, identification, and growth characteristics. In Vitro Cell Dev Biol. 1993 Feb;29A(2):127–134. doi: 10.1007/BF02630943. [DOI] [PubMed] [Google Scholar]
  34. Prutkin L. Mucous metaplasia and gap junctions in the vitamin A acid-treated skin tumor, keratoacanthoma. Cancer Res. 1975 Feb;35(2):364–369. [PubMed] [Google Scholar]
  35. Shasby D. M., Lind S. E., Shasby S. S., Goldsmith J. C., Hunninghake G. W. Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood. 1985 Mar;65(3):605–614. [PubMed] [Google Scholar]
  36. Shinkai K., Mukai M., Akedo H. Superoxide radical potentiates invasive capacity of rat ascites hepatoma cells in vitro. Cancer Lett. 1986 Jul;32(1):7–13. doi: 10.1016/0304-3835(86)90033-9. [DOI] [PubMed] [Google Scholar]
  37. Shinkai K., Mukai M., Horai T., Ohigashi H., Nishikawa S., Inoue H., Takeda Y., Akedo H. Inhibition of in vitro tumor cell invasion by transmethylation inhibitors. Jpn J Cancer Res. 1989 Aug;80(8):716–719. doi: 10.1111/j.1349-7006.1989.tb01703.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Shinkai K., Mukai M., Komatsu K., Akedo H. Factor from rat liver with antiinvasive potential on rat ascites hepatoma cells. Cancer Res. 1988 Jul 1;48(13):3760–3764. [PubMed] [Google Scholar]
  39. Singh G., Dekker A., Ladoulis C. T. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology. Acta Cytol. 1978 Nov-Dec;22(6):487–489. [PubMed] [Google Scholar]
  40. Staddon J. M., Herrenknecht K., Smales C., Rubin L. L. Evidence that tyrosine phosphorylation may increase tight junction permeability. J Cell Sci. 1995 Feb;108(Pt 2):609–619. doi: 10.1242/jcs.108.2.609. [DOI] [PubMed] [Google Scholar]
  41. Stevenson B. R., Siliciano J. D., Mooseker M. S., Goodenough D. A. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986 Sep;103(3):755–766. doi: 10.1083/jcb.103.3.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tang D. G., Timar J., Grossi I. M., Renaud C., Kimler V. A., Diglio C. A., Taylor J. D., Honn K. V. The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp Cell Res. 1993 Aug;207(2):361–375. doi: 10.1006/excr.1993.1203. [DOI] [PubMed] [Google Scholar]
  43. Thiollet J., Jaurand M. C., Kaplan H., Bignon J., Hollande E. Culture procedure of mesothelial cells from the rat parietal pleura. Biomedicine. 1978 Apr;29(2):69–73. [PubMed] [Google Scholar]
  44. Uchiyama A., Kitsuki H., Shimura H., Torisu M. Suppression by interferon-gamma of tumor cell-induced increase in mesothelial permeability. Clin Exp Metastasis. 1992 Nov;10(6):371–378. doi: 10.1007/BF00133465. [DOI] [PubMed] [Google Scholar]
  45. Wu Y. J., Parker L. M., Binder N. E., Beckett M. A., Sinard J. H., Griffiths C. T., Rheinwald J. G. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell. 1982 Dec;31(3 Pt 2):693–703. doi: 10.1016/0092-8674(82)90324-5. [DOI] [PubMed] [Google Scholar]
  46. Zhong Y., Enomoto K., Isomura H., Sawada N., Minase T., Oyamada M., Konishi Y., Mori M. Localization of the 7H6 antigen at tight junctions correlates with the paracellular barrier function of MDCK cells. Exp Cell Res. 1994 Oct;214(2):614–620. doi: 10.1006/excr.1994.1299. [DOI] [PubMed] [Google Scholar]
  47. Zhong Y., Saitoh T., Minase T., Sawada N., Enomoto K., Mori M. Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2. J Cell Biol. 1993 Jan;120(2):477–483. doi: 10.1083/jcb.120.2.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. van Hinsbergh V. W., Kooistra T., Scheffer M. A., Hajo van Bockel J., van Muijen G. N. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood. 1990 Apr 1;75(7):1490–1497. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES